Local failure after complete resection of N0–1 non-small cell lung cancer

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

Robert J. Ginsberg · The Annals of Thoracic Surgery · 1995 · 3K citations

Surgical Oncology, Medicine, Cancer Management +8

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.6K citations · Full text

Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

New England Journal of Medicine · 2004 · 2.3K citations

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Surgical Oncology, Cisplatin Versus Observation, Medicine +10

Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Mary V. Graham, James A. Purdy, Bahman Emami et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 1.2K citations

Medical Imaging, Advanced Lung Disease, Medicine +7